FORA Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

FORA Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-26,640	Closed	-$2.74M	–	620
2023 Q2	$2.74M	Sell	26,640 -1,202	-4%	-$127K	0.39%	77
2023 Q1	$3.04M	Buy	+27,842	New	+$3.08M	0.3%	102
2021 Q4	–	Sell	-3,952	Closed	-$433K	–	514
2021 Q3	$433K	Sell	3,952 -4,406	-53%	-$457K	0.11%	224
2021 Q2	$783K	Buy	+8,358	New	+$769K	0.15%	181

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FORA Capital's HZNP Position: Q3 2023 in Review

FORA Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 26,640 shares — an estimated $2.74M sold.

FORA Capital first reported a position in HZNP in Q2 2021 and held it in 4 quarters. The position peaked at $3.04M in Q1 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

FORA Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
FORA Capital sold 26,640 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $2.74M.
FORA Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 4 quarters.
FORA Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.04M in Q1 2023.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on FORA Capital's 13F filing for Q3 2023, filed 13 Nov 2023.